Apterna is pre-clinical biotechnology company developing chemically synthesized RNA aptamers that bind to target molecules with outstanding specificity and affinity. They are developing internalizing RNA aptamers that enable targeted delivery of various payloads including RNA, toxins, enzymes, chemotherapy agents, photodynamic molecules, radionuclides, and nanocarriers.
Menu